{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:16:27Z","timestamp":1791112587756,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/gt.2013.36","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T10:19:25Z","timestamp":1372328365000},"page":"1093-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization"],"prefix":"10.1038","volume":"20","author":[{"given":"M","family":"El Sanharawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bigey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Escriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Naud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Berdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C","family":"Jeanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"BFgt201336_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1517\/14712598.2012.660523","volume":"12","author":"DS Dhoot","year":"2012","unstructured":"Dhoot DS, Kaiser PK . Ranibizumab for age-related macular degeneration. Expert Opin Biol Ther 2012; 12: 371\u2013381.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt201336_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajo.2012.04.020","volume":"154","author":"DJ Browning","year":"2012","unstructured":"Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW . Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol 2012; 154: 222\u2013226.","journal-title":"Am J Ophthalmol"},{"key":"BFgt201336_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1517\/14656566.2012.658368","volume":"13","author":"M Ohr","year":"2012","unstructured":"Ohr M, Kaiser PK . Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opin Pharmacother 2012; 13: 585\u2013591.","journal-title":"Expert Opin Pharmacother"},{"key":"BFgt201336_CR4","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ophtha.2012.07.041","volume":"119","author":"PS Muether","year":"2012","unstructured":"Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S . Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Ophthalmology 2012; 119: 2082\u20132086.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"BFgt201336_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000337157","volume":"227","author":"PA Campochiaro","year":"2012","unstructured":"Campochiaro PA . Anti-vascular endothelial growth factor treatment for retinal vein occlusions. Ophthalmologica 2012; 227 (Suppl 1): 30\u201335.","journal-title":"Ophthalmologica"},{"key":"BFgt201336_CR6","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.ophtha.2012.07.058","volume":"119","author":"AC Ho","year":"2012","unstructured":"Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS et al. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the american academy of ophthalmology. Ophthalmology 2012; 119: 2179\u20132188.","journal-title":"Ophthalmology"},{"key":"BFgt201336_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjophthalmol-2011-300674","volume":"96","author":"I Zechmeister-Koss","year":"2012","unstructured":"Zechmeister-Koss I, Huic M . Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review. Br J Ophthalmol 2012; 96: 167\u2013178.","journal-title":"Br J Ophthalmol"},{"key":"BFgt201336_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.preteyeres.2010.04.001","volume":"29","author":"M El Sanharawi","year":"2010","unstructured":"El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F . Protein delivery for retinal diseases: from basic considerations to clinical applications. Prog Retin Eye Res 2010; 29: 443\u2013465.","journal-title":"Prog Retin Eye Res"},{"key":"BFgt201336_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","volume":"29","author":"AV Cideciyan","year":"2010","unstructured":"Cideciyan AV . Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res 2010; 29: 398\u2013427.","journal-title":"Prog Retin Eye Res"},{"key":"BFgt201336_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00417-012-2028-2","volume":"250","author":"RB Hufnagel","year":"2012","unstructured":"Hufnagel RB, Ahmed ZM, Correa ZM, Sisk RA . Gene therapy for Leber congenital amaurosis: advances and future directions. Graefes Arch Clin Exp Ophthalmol 2012; 250: 1117\u20131128.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFgt201336_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/gt.2011.161","volume":"19","author":"AJ Smith","year":"2012","unstructured":"Smith AJ, Bainbridge JW, Ali RR . Gene supplementation therapy for recessive forms of inherited retinal dystrophies. Gene Ther 2012; 19: 154\u2013161.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.gt.3301680","volume":"9","author":"JW Bainbridge","year":"2002","unstructured":"Bainbridge JW, Mistry A, De Alwis M, Paleolog E, Baker A, Thrasher AJ et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 2002; 9: 320\u2013326.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR13","first-page":"75","volume":"19","author":"J Ideno","year":"2007","unstructured":"Ideno J, Mizukami H, Kakehashi A, Saito Y, Okada T, Urabe M et al. Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model. Int J Mol Med 2007; 19: 75\u201379.","journal-title":"Int J Mol Med"},{"key":"BFgt201336_CR14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1089\/hum.2011.090","volume":"22","author":"Y Mao","year":"2011","unstructured":"Mao Y, Kiss S, Boyer JL, Hackett NR, Qiu J, Carbone A et al. Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab. Hum Gene Ther 2011; 22: 1525\u20131535.","journal-title":"Hum Gene Ther"},{"key":"BFgt201336_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gt.2008.115","volume":"16","author":"P Pechan","year":"2009","unstructured":"Pechan P, Rubin H, Lukason M, Ardinger J, DuFresne E, Hauswirth WW et al. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther 2009; 16: 10\u201316.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ymthe.2004.09.022","volume":"11","author":"N Provost","year":"2005","unstructured":"Provost N, Le Meur G, Weber M, Mendes-Madeira A, Podevin G, Cherel Y et al. Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol Ther 2005; 11: 275\u2013283.","journal-title":"Mol Ther"},{"key":"BFgt201336_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/mt.2008.283","volume":"17","author":"K Stieger","year":"2009","unstructured":"Stieger K, Schroeder J, Provost N, Mendes-Madeira A, Belbellaa B, Le Meur G et al. Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther 2009; 17: 516\u2013523.","journal-title":"Mol Ther"},{"key":"BFgt201336_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1517\/14712598.6.7.717","volume":"6","author":"W Tao","year":"2006","unstructured":"Tao W . Application of encapsulated cell technology for retinal degenerative diseases. Expert Opin Biol Ther 2006; 6: 717\u2013726.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt201336_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/jgm.1517","volume":"12","author":"E Touchard","year":"2010","unstructured":"Touchard E, Kowalczuk L, Bloquel C, Naud MC, Bigey P, Behar-Cohen F . The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins. J Gene Med 2010; 12: 904\u2013919.","journal-title":"J Gene Med"},{"key":"BFgt201336_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.1312256","volume":"255","author":"C de Vries","year":"1992","unstructured":"de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT . The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989\u2013991.","journal-title":"Science"},{"key":"BFgt201336_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1083\/jcb.129.4.895","volume":"129","author":"T Mustonen","year":"1995","unstructured":"Mustonen T, Alitalo K . Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995; 129: 895\u2013898.","journal-title":"J Cell Biol"},{"key":"BFgt201336_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/mend.13.4.0265","volume":"13","author":"Y He","year":"1999","unstructured":"He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS . Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999; 13: 537\u2013545.","journal-title":"Mol Endocrinol"},{"key":"BFgt201336_CR23","doi-asserted-by":"publisher","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","volume":"90","author":"RL Kendall","year":"1993","unstructured":"Kendall RL, Thomas KA . Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90: 10705\u201310709.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201336_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","volume":"226","author":"RL Kendall","year":"1996","unstructured":"Kendall RL, Wang G, Thomas KA . Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226: 324\u2013328.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201336_CR25","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1074\/jbc.272.16.10382","volume":"272","author":"B Barleon","year":"1997","unstructured":"Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G et al. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem 1997; 272: 10382\u201310388.","journal-title":"J Biol Chem"},{"key":"BFgt201336_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1006\/bbrc.1997.6156","volume":"231","author":"SA Cunningham","year":"1997","unstructured":"Cunningham SA, Stephan CC, Arrate MP, Ayer KG, Brock TA . Identification of the extracellular domains of Flt-1 that mediate ligand interactions. Biochem Biophys Res Commun 1997; 231: 596\u2013599.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201336_CR27","doi-asserted-by":"publisher","first-page":"F928","DOI":"10.1152\/ajprenal.00596.2007","volume":"294","author":"DP Basile","year":"2008","unstructured":"Basile DP, Fredrich K, Chelladurai B, Leonard EC, Parrish AR . Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 2008; 294: F928\u2013F936.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFgt201336_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/104303403321070829","volume":"14","author":"P Gehlbach","year":"2003","unstructured":"Gehlbach P, Demetriades AM, Yamamoto S, Deering T, Xiao WH, Duh EJ et al. Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier. Hum Gene Ther 2003; 14: 129\u2013141.","journal-title":"Hum Gene Ther"},{"key":"BFgt201336_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/hum.2009.153","volume":"21","author":"T Igarashi","year":"2010","unstructured":"Igarashi T, Miyake K, Masuda I, Takahashi H, Shimada T . Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model. Hum Gene Ther 2010; 21: 631\u2013637.","journal-title":"Hum Gene Ther"},{"key":"BFgt201336_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ymthe.2005.04.022","volume":"12","author":"CM Lai","year":"2005","unstructured":"Lai CM, Shen WY, Brankov M, Lai YK, Barnett NL, Lee SY et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 2005; 12: 659\u2013668.","journal-title":"Mol Ther"},{"key":"BFgt201336_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/sj.gt.3301695","volume":"9","author":"YK Lai","year":"2002","unstructured":"Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE . Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 2002; 9: 804\u2013813.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/exer.2000.0907","volume":"71","author":"JL Edelman","year":"2007","unstructured":"Edelman JL, Castro MR . Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 2007; 71: 523\u2013533.","journal-title":"Exp Eye Res"},{"key":"BFgt201336_CR33","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/IAE.0b013e3181ad240c","volume":"29","author":"PK Kaiser","year":"2009","unstructured":"Kaiser PK . Strategies for inhibiting vascular endothelial growth factor. Retina 2009; 29: S15\u2013S17.","journal-title":"Retina"},{"key":"BFgt201336_CR34","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW . Diabetic retinopathy. N Engl J Med 2012; 366: 1227\u20131239.","journal-title":"N Engl J Med"},{"key":"BFgt201336_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9440(10)64891-2","volume":"160","author":"K Ohno-Matsui","year":"2002","unstructured":"Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 2002; 160: 711\u2013719.","journal-title":"Am J Pathol"},{"key":"BFgt201336_CR36","first-page":"281","volume":"151","author":"N Okamoto","year":"1997","unstructured":"Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W et al. Transgenic mce with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151: 281\u2013291.","journal-title":"Am J Pathol"},{"key":"BFgt201336_CR37","first-page":"87","volume":"16","author":"E Yamada","year":"2001","unstructured":"Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z et al. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol 2001; 16: 87\u201397.","journal-title":"Histol Histopathol"},{"key":"BFgt201336_CR38","doi-asserted-by":"publisher","first-page":"786870","DOI":"10.1155\/2012\/786870","volume":"2012","author":"JL Kovach","year":"2012","unstructured":"Kovach JL, Schwartz SG, Flynn HW Jr., Scott IU . Anti-VEGF treatment strategies for wet AMD. J Ophthalmol 2012; 2012: 786870.","journal-title":"J Ophthalmol"},{"key":"BFgt201336_CR39","doi-asserted-by":"publisher","first-page":"e17462","DOI":"10.1371\/journal.pone.0017462","volume":"6","author":"L Kowalczuk","year":"2011","unstructured":"Kowalczuk L, Touchard E, Omri S, Jonet L, Klein C, Valamanes F et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One 2011; 6: e17462.","journal-title":"PLoS One"},{"key":"BFgt201336_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00125-006-0539-2","volume":"50","author":"N Miyamoto","year":"2007","unstructured":"Miyamoto N, de Kozak Y, Jeanny JC, Glotin A, Mascarelli F, Massin P et al. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. Diabetologia 2007; 50: 461\u2013470.","journal-title":"Diabetologia"},{"key":"BFgt201336_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000119877","volume":"40","author":"N Miyamoto","year":"2008","unstructured":"Miyamoto N, de Kozak Y, Normand N, Courtois Y, Jeanny JC, Benezra D et al. PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema. Ophthalmic Res 2008; 40: 203\u2013207.","journal-title":"Ophthalmic Res"},{"key":"BFgt201336_CR42","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/sj.gt.3302579","volume":"12","author":"RJ Marano","year":"2005","unstructured":"Marano RJ, Toth I, Wimmer N, Brankov M, Rakoczy PE . Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. Gene Ther 2005; 12: 1544\u20131550.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/mt.2010.230","volume":"19","author":"M Lukason","year":"2011","unstructured":"Lukason M, DuFresne E, Rubin H, Pechan P, Li Q, Kim I et al. Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule. Mol Ther 2011; 19: 260\u2013265.","journal-title":"Mol Ther"},{"key":"BFgt201336_CR44","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et alMARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419\u20131431.","journal-title":"N Engl J Med"},{"key":"BFgt201336_CR45","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1073\/pnas.0905010106","volume":"106","author":"M Saint-Geniez","year":"2009","unstructured":"Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D\u2019Amore PA . An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 2009; 106: 18751\u201318756.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201336_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IAE.0b013e3182657fff","volume":"33","author":"N Lois","year":"2013","unstructured":"Lois N, McBain V, Abdelkader E, Scott NW, Kumari R . Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy. Retina 2013; 33: 13\u201322.","journal-title":"Retina"},{"key":"BFgt201336_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/gt.2011.154","volume":"19","author":"E Touchard","year":"2012","unstructured":"Touchard E, Heiduschka P, Berdugo M, Kowalczuk L, Bigey P, Chahory S et al. Non-viral gene therapy for GDNF production in RCS rat: the crucial role of the plasmid dose. Gene Ther 2012; 19: 886\u2013898.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR48","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/gt.2009.43","volume":"16","author":"E Touchard","year":"2009","unstructured":"Touchard E, Bloquel C, Bigey P, Kowalczuk L, Jonet L, Thillaye-Goldenberg B et al. Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis. Gene Ther 2009; 16: 862\u2013873.","journal-title":"Gene Ther"},{"key":"BFgt201336_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000330279","volume":"47","author":"F Drechsler","year":"2012","unstructured":"Drechsler F, Koferl P, Hollborn M, Wiedemann P, Bringmann A, Kohen L et al. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion. Ophthalmic Res 2012; 47: 157\u2013162.","journal-title":"Ophthalmic Res"},{"key":"BFgt201336_CR50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/10641950902777721","volume":"28","author":"B Xu","year":"2009","unstructured":"Xu B, Thornton C, Tooher J, Hennessy A . Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1\/Th2 cytokine production from normal placental explants via intracellular calcium. Hypertens Pregnancy 2009; 28: 448\u2013456.","journal-title":"Hypertens Pregnancy"},{"key":"BFgt201336_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jgm.1547","volume":"13","author":"FG Rocha","year":"2011","unstructured":"Rocha FG, Calvo FB, Chaves KC, Peron JP, Marques RF, de Borba TR et al. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. J Gene Med 2011; 13: 148\u2013157.","journal-title":"J Gene Med"},{"key":"BFgt201336_CR52","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/sj.bjc.6605438","volume":"101","author":"G Al\u00ec","year":"2009","unstructured":"Al\u00ec G, Boldrini L, Lucchi M, Picchi A, Dell\u2019Omodarme M, Prati MC et al. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. Br J Cancer 2009; 101: 1869\u20131875.","journal-title":"Br J Cancer"},{"key":"BFgt201336_CR53","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/WNR.0b013e3283036e88","volume":"19","author":"S Girard","year":"2008","unstructured":"Girard S, Larouche A, Kadhim H, Rola-Pleszczynski M, Gobeil F, S\u00e9bire G . Lipopolysaccharide and hypoxia\/ischemia induced IL-2 expression by microglia in neonatal brain. Neuroreport 2008; 19: 997\u20131002.","journal-title":"Neuroreport"},{"key":"BFgt201336_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW . Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 2009; 29: 523\u2013529.","journal-title":"Retina"},{"key":"BFgt201336_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1523\/JNEUROSCI.2888-08.2009","volume":"29","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG . Microglial VEGF receptor response is an integral chemotactic component in Alzheimer\u2019s disease pathology. J Neurosci 2009; 29: 3\u201313.","journal-title":"J Neurosci"},{"key":"BFgt201336_CR56","first-page":"797","volume":"18","author":"SA Vinores","year":"2003","unstructured":"Vinores SA, Xiao WH, Zimmerman R, Whitcup SM, Wawrousek EF . Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL-1beta) in the lens and mice undergoing retinal degeneration. Histol Histopathol 2003; 18: 797\u2013810.","journal-title":"Histol Histopathol"},{"key":"BFgt201336_CR57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jgm.922","volume":"8","author":"M Khoury","year":"2006","unstructured":"Khoury M, Bigey P, Louis-Plence P, Noel D, Rhinn H, Scherman D et al. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med 2006; 8: 1027\u20131036.","journal-title":"J Gene Med"},{"key":"BFgt201336_CR58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0092-8674(00)80456-0","volume":"91","author":"C Wiesmann","year":"1997","unstructured":"Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM . Crystal structure at 1.7A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 1997; 91: 695\u2013704.","journal-title":"Cell"},{"key":"BFgt201336_CR59","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201336_CR60","first-page":"519","volume":"5","author":"M Shibuya","year":"1990","unstructured":"Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990; 5: 519\u2013524.","journal-title":"Oncogene"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:16:46Z","timestamp":1648552606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFgt201336"],"URL":"https:\/\/doi.org\/10.1038\/gt.2013.36","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]},"assertion":[{"value":"24 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}